These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36959084)

  • 21. Microfluidics for cell factory and bioprocess development.
    Bjork SM; Joensson HN
    Curr Opin Biotechnol; 2019 Feb; 55():95-102. PubMed ID: 30236890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Science-based bioprocess design for filamentous fungi.
    Posch AE; Herwig C; Spadiut O
    Trends Biotechnol; 2013 Jan; 31(1):37-44. PubMed ID: 23183302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A carbon dioxide stripping model for mammalian cell culture in manufacturing scale bioreactors.
    Xing Z; Lewis AM; Borys MC; Li ZJ
    Biotechnol Bioeng; 2017 Jun; 114(6):1184-1194. PubMed ID: 27922179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hybrid mechanistic-empirical model for in silico mammalian cell bioprocess simulation.
    O'Brien CM; Zhang Q; Daoutidis P; Hu WS
    Metab Eng; 2021 Jul; 66():31-40. PubMed ID: 33813033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated biological sulphate reduction: a review on mathematical models, monitoring and bioprocess control.
    Cassidy J; Lubberding HJ; Esposito G; Keesman KJ; Lens PN
    FEMS Microbiol Rev; 2015 Nov; 39(6):823-53. PubMed ID: 26229081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microfluidic single-cell scale-down systems: introduction, application, and future challenges.
    Täuber S; Grünberger A
    Curr Opin Biotechnol; 2023 Jun; 81():102915. PubMed ID: 36871470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating environmental impacts of early-stage bioprocesses.
    Wowra K; Hegel E; Scharf A; Grünberger A; Rosenthal K
    Trends Biotechnol; 2023 Sep; 41(9):1199-1212. PubMed ID: 37188575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of agent-based system for bioprocess description and process improvement.
    Gao Y; Kipling K; Glassey J; Willis M; Montague G; Zhou Y; Titchener-Hooker NJ
    Biotechnol Prog; 2010; 26(3):706-16. PubMed ID: 20014420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclotide synthesis and supply: from plant to bioprocess.
    Dörnenburg H
    Biopolymers; 2010; 94(5):602-10. PubMed ID: 20564040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel probes for pH and dissolved oxygen measurements in cultivations from millilitre to benchtop scale.
    Demuth C; Varonier J; Jossen V; Eibl R; Eibl D
    Appl Microbiol Biotechnol; 2016 May; 100(9):3853-63. PubMed ID: 26995606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digital Twins for Bioprocess Control Strategy Development and Realisation.
    Appl C; Moser A; Baganz F; Hass VC
    Adv Biochem Eng Biotechnol; 2021; 177():63-94. PubMed ID: 33215237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model predictive control for steady-state performance in integrated continuous bioprocesses.
    Pappenreiter M; Döbele S; Striedner G; Jungbauer A; Sissolak B
    Bioprocess Biosyst Eng; 2022 Sep; 45(9):1499-1513. PubMed ID: 35915164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving embryonic stem cell expansion through the combination of perfusion and Bioprocess model design.
    Yeo D; Kiparissides A; Cha JM; Aguilar-Gallardo C; Polak JM; Tsiridis E; Pistikopoulos EN; Mantalaris A
    PLoS One; 2013; 8(12):e81728. PubMed ID: 24339957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scale-up/Scale-down of microbial bioprocesses: a modern light on an old issue.
    Delvigne F; Noorman H
    Microb Biotechnol; 2017 Jul; 10(4):685-687. PubMed ID: 28556613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.
    Jenkins MJ; Farid SS
    Biotechnol J; 2015 Jan; 10(1):83-95. PubMed ID: 25524780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid physics-based and data-driven modeling for bioprocess online simulation and optimization.
    Zhang D; Del Rio-Chanona EA; Petsagkourakis P; Wagner J
    Biotechnol Bioeng; 2019 Nov; 116(11):2919-2930. PubMed ID: 31317536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Model-based analysis on the relationship of signal quality to real-time extraction of information in bioprocesses.
    Wechselberger P; Herwig C
    Biotechnol Prog; 2012; 28(1):265-75. PubMed ID: 21954135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taking control over microbial populations: Current approaches for exploiting biological noise in bioprocesses.
    Delvigne F; Baert J; Sassi H; Fickers P; Grünberger A; Dusny C
    Biotechnol J; 2017 Jul; 12(7):. PubMed ID: 28544731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immersed membrane bioreactors: an overview with special emphasis on anaerobic bioprocesses.
    Singhania RR; Christophe G; Perchet G; Troquet J; Larroche C
    Bioresour Technol; 2012 Oct; 122():171-80. PubMed ID: 22382296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.